Sign In

Carla Mellough

Director of Pharmacology at PYC Therapeutics. Head of the Retinal Organoid Laboratory at the Lions Eye Institute.

Carla Mellough is the Director of Pharmacology at PYC Therapeutics, a company focused on developing treatments for genetic diseases using RNA-based approaches.1 Her professional background includes:

Education and Research

Carla holds a BSc in Anatomy and Human Biology and a PhD in Neuroscience from the University of Western Australia.2 She has been involved in academic research, with a particular focus on:

  • Retinal diseases and development
  • Gene, drug, and cell-based therapies for Usher syndrome
  • Mechanisms of cone migration in the mammalian retina3

Current Role

As Director of Pharmacology at PYC Therapeutics, Carla leads the development of treatments for genetic diseases. Her responsibilities likely include:

  • Overseeing pharmacological aspects of drug development
  • Guiding research strategies for RNA-based therapies
  • Managing teams working on genetic disease treatments

Research Affiliations

Carla has been associated with:

  • Lions Eye Institute in Western Australia2
  • Frontiers, where she has contributed to scientific publications3

Impact and Recognition

Carla's expertise in retinal biology and genetic diseases has positioned her as a key figure in the field. Her work at PYC Therapeutics involves translating scientific research into potential therapeutic applications, particularly in the area of RNA-based treatments for genetic disorders.

Related Questions

What are Carla Mellough's main responsibilities at PYC Therapeutics?
What specific genetic diseases is Carla Mellough focusing on at PYC Therapeutics?
How did Carla Mellough transition from the Lions Eye Institute to PYC Therapeutics?
What are some notable achievements of Carla Mellough in her career?
What is Carla Mellough's educational background?
Carla Mellough
Carla Mellough, photo 1
Carla Mellough, photo 2
Add to my network

Location

Nedlands, Western Australia, Australia